ID

13475

Descripción

Randomized Phase III Study of Intensive Chemotherapy with or without Dasatinib (Sprycel(TM)) in Adult Patients with Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)

Palabras clave

Versiones (5)
  1. 5/3/15 5/3/15 -
  2. 9/3/15 9/3/15 -
  3. 24/4/15 24/4/15 -
  4. 15/12/15 15/12/15 -
  5. 11/2/16 11/2/16 -
Subido en

11 de febrero de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

End of Study AMLSG 21-13 DRKS00007189 NCT02013648 Akute myeloische Leukämie (AML)

Inglés

End of Study AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)

1 formularios  
End of Study
Descripción

End of Study

End of Study Date
Descripción

End of Study Date

Tipo de datos

date

Alias
UMLS CUI-1
C2983670
Reason for End of Study
Descripción

Reason for End of Study

Tipo de datos

integer

Alias
UMLS CUI-1
C2348577
Specify if Reason for End of Study = 6 or 7
Descripción

Specify if Reason for End of Study = 6 or 7

Tipo de datos

text

Alias
UMLS CUI [1]
C1521902
Induction therapy I administered
Descripción

Induction therapy I administered

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3179010
UMLS CUI [1,2]
C0806914
UMLS CUI [1,3]
C0205447
Induction therapy II administered
Descripción

Induction therapy II administered

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3179010
UMLS CUI [1,2]
C0806914
UMLS CUI [1,3]
C0205448
Consolidation therapy I administered
Descripción

Consolidation therapy I administered

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3179017
UMLS CUI [1,2]
C0806914
UMLS CUI [1,3]
C0205447
Consolidation therapy II administered
Descripción

Consolidation therapy II administered

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3179017
UMLS CUI [1,2]
C0806914
UMLS CUI [1,3]
C0205448
Consolidation therapy III administered
Descripción

Consolidation therapy III administered

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3179017
UMLS CUI [1,2]
C0806914
UMLS CUI [1,3]
C0205449
Consolidation therapy IV administered
Descripción

Consolidation therapy IV administered

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3179017
UMLS CUI [1,2]
C0806914
UMLS CUI [1,3]
C0205450
Maintenance therapy administered
Descripción

Maintenance therapy administered

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0481504
UMLS CUI [1,2]
C0806914
Signature
Descripción

Signature

Date
Descripción

Date

Tipo de datos

date

Alias
UMLS CUI-1
C0011008
Name of Investigator
Descripción

Name of Investigator

Tipo de datos

text

Alias
UMLS CUI-1
C2826892
Signature of investigator
Descripción

Signature of investigator

Tipo de datos

text

Alias
UMLS CUI-1
C2346576
Volver a la parte superior de la página

Similar models

End of Study AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
End of Study
End of Study Date
Item
End of Study Date
date
C2983670 (UMLS CUI-1)
Item
Reason for End of Study
integer
C2348577 (UMLS CUI-1)
Reason for End of Study
Code List
Reason for End of Study
CL Item
regular End of Study (0)
C0205272 (UMLS CUI-1)
CL Item
no CR after Induction (Progressive Disease) (1)
C1335499 (UMLS CUI-1)
CL Item
exzessive extramedullary medical toxicity (2)
C0013221 (UMLS CUI-1)
CL Item
death (3)
C0021430 (UMLS CUI-1)
CL Item
relapse after CR (4)
C0035020 (UMLS CUI-1)
CL Item
Withdrawal of informed consent (5)
C0021430 (UMLS CUI-1)
C1710677 (UMLS CUI-2)
CL Item
Protocol deviation (6)
C1705236 (UMLS CUI-1)
CL Item
other (7)
C0205394 (UMLS CUI-1)
Specify if Reason for End of Study = 6 or 7
Item
Specify if Reason for End of Study = 6 or 7
text
C1521902 (UMLS CUI [1])
Induction therapy I administered
Item
Induction therapy I administered
boolean
C3179010 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
C0205447 (UMLS CUI [1,3])
Induction therapy II administered
Item
Induction therapy II administered
boolean
C3179010 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
C0205448 (UMLS CUI [1,3])
Consolidation therapy I administered
Item
Consolidation therapy I administered
boolean
C3179017 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
C0205447 (UMLS CUI [1,3])
Consolidation therapy II administered
Item
Consolidation therapy II administered
boolean
C3179017 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
C0205448 (UMLS CUI [1,3])
Consolidation therapy III administered
Item
Consolidation therapy III administered
boolean
C3179017 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
C0205449 (UMLS CUI [1,3])
Consolidation therapy IV administered
Item
Consolidation therapy IV administered
boolean
C3179017 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
C0205450 (UMLS CUI [1,3])
Maintenance therapy administered
Item
Maintenance therapy administered
boolean
C0481504 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
Item Group
Signature
Date
Item
Date
date
C0011008 (UMLS CUI-1)
Name of Investigator
Item
Name of Investigator
text
C2826892 (UMLS CUI-1)
Signature of investigator
Item
Signature of investigator
text
C2346576 (UMLS CUI-1)
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial